IRB #

STUDY00016373

Title

A Pilot Study Investigating 18F-FLT-PET as a Marker of Response to Preoperative Radiotherapy in Soft Tissue Sarcoma

Principal Investigator

Arthur Hung

Study Purpose

The purpose of this study is to find out how accurate and useful a new imaging technique, a type of PET scan that uses labeled thymidine, is in assessing the response of extremity soft tissue sarcomas to radiation treatment.

Medical Condition(s)

Extremity soft tissue sarcoma

Eligibility Criteria

Participants are patients with histologically confirmed intermediate or high grade soft tissue sarcoma, who have gross disease defined as ≥ 1cm visible on CT or MRI and who plan to be treated with neoadjuvant radiotherapy and resection. Participants must be greater than 18 years of age.

Age Range

18 - 100

Healthy Volunteers Needed

No

Duration of Participation

This study will not add additional time to your treatment. We will follow you through your medical records and regularly scheduled visits for 3 years after your treatment.

Minors Included

No

Contact

Christina Binder
Radiation Medicine
503-494-8756

Sponsor

N/A

Recruitment End

11/30/2018

Compensation Provided

No


Go Back